SIA
DMIIR

SkyView Investment Advisors’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

SkyView Investment Advisors’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Buy
+250,000
New +$21.4K 0.02% 184

Other funds holding DMIIR

MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

SkyView Investment Advisors's DMIIR Position: Q2 2026 in Review

SkyView Investment Advisors opened a new position in Drugs Made In America Acquisition II Corp Right (DMIIR) in Q2 2026: 250,000 shares worth $20K. The stake represents 0.02% of the portfolio and ranks #184 among its holdings.

62 funds tracked by Wall St. Rank hold DMIIR as of Q2 2026.

  • SkyView Investment Advisors held 250,000 shares of Drugs Made In America Acquisition II Corp Right worth $20K as of Q2 2026.
  • Drugs Made In America Acquisition II Corp Right was a new SkyView Investment Advisors position in Q2 2026.
  • Drugs Made In America Acquisition II Corp Right made up 0.02% of SkyView Investment Advisors's portfolio in Q2 2026, its #184 holding.
  • 62 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q2 2026.

Based on SkyView Investment Advisors's 13F filing for Q2 2026, filed 15 Sep 2026.